Gut mycobiome alterations and network interactions with the bacteriome in patients with atherosclerotic cardiovascular disease DOI Creative Commons
Guangming Su, Ping Huang, Dan Liu

et al.

Microbiology Spectrum, Journal Year: 2024, Volume and Issue: 13(1)

Published: Dec. 11, 2024

ABSTRACT The connection between the gut mycobiome and atherosclerotic cardiovascular disease (ACVD) is largely uncharted. In our study, we compared fungal communities of 214 ACVD patients with those 171 healthy controls using shotgun metagenomic sequencing examined their interactions bacterial network key taxa. composition in significantly different, showing a rise opportunistic pathogens like Candida albicans , Exophiala spinifera Malassezia restricta most significant changes (Wilcoxon rank-sum test, P < 0.001, fold change >10). Network analysis revealed less interconnected more uneven microbial patients. taxa identified microbiome include globosa c182, Nakaseomyces glabratus c88, arunalokei c192, Penicillium sumatraense c22. Predictive models that integrated both enhanced prediction accuracy, underscoring critical role fungi ACVD. Our findings offer thorough understanding link progression, which vital for directing future therapeutic research. IMPORTANCE leading cause death morbidity worldwide. While development recognized, contribution remains unexplored. study reveals alterations identifies associated disease. These underscore importance pathogenesis new avenues developing preventive strategies targeting community. results provide valuable insights into complex interplay bacteria ACVD, paving way novel approaches.

Language: Английский

Maternal exercise prevents metabolic disorders in offspring mice through SERPINA3C DOI
Yang Li, Ruo-Ying Li,

Jieying Zhu

et al.

Nature Metabolism, Journal Year: 2025, Volume and Issue: unknown

Published: Jan. 31, 2025

Language: Английский

Citations

1

Development of an underutilized part of Syzygium aromaticum based on phytochemical and bioactivity assessment DOI
Shufang Yang,

Xiaoxue Jiang,

Ren Xu

et al.

Food Chemistry, Journal Year: 2025, Volume and Issue: unknown, P. 144072 - 144072

Published: March 1, 2025

Language: Английский

Citations

1

Milestones in the journey towards addressing obesity; Past trials and triumphs, recent breakthroughs, and an exciting future in the era of emerging effective medical therapies and integration of effective medical therapies with metabolic surgery DOI Open Access
Michail Kokkorakis, Angeliki Katsarou, Niki Katsiki

et al.

Metabolism, Journal Year: 2023, Volume and Issue: 148, P. 155689 - 155689

Published: Sept. 7, 2023

Language: Английский

Citations

21

Relationship Between Systemic Inflammatory Response Exponents, Levels of ADAM10, ADAM17 Proteins and Selected Clinical Parameters in Patients with Colorectal Cancer: Original Research Study DOI Open Access
Magdalena Sikora-Skrabaka, Katarzyna Walkiewicz, Dariusz Waniczek

et al.

International Journal of Molecular Sciences, Journal Year: 2025, Volume and Issue: 26(3), P. 1104 - 1104

Published: Jan. 27, 2025

Chronic inflammation is a confirmed risk factor for colorectal cancer (CRC). Indicators of systemic inflammatory response (SIR), such as neutrophil-to-lymphocyte ratio (NLR) or platelet-to-lymphocyte (PLR), are easily accessible indicators the generalized response. At molecular level, inflammation-related carcinogenesis involves proteins from adamalysin family: ADAM10 and ADAM17. The aim study was to assess NLR PLR their relationship with selected clinical parameters in CRC patients, well correlation between ADAM17 tumor tissue matched surgical margins values. Tumor material margins, blood collected 66 patients who underwent surgery because CRC. concentrations were tested using enzyme-linked immunosorbent assay (ELISA) method. SIR (NLR, PLR) also determined. results statistically analyzed compared parameters. Results: showed that lower comorbid cardiovascular diseases (CVD). In preoperative treatment, both values higher than primary surgery. There negative margin conclusion, presence additional CVD diabetes mellitus type 2 (DMT2) use treatment should be taken into account when assessing patients. Moreover, no clear correlations have been found

Language: Английский

Citations

0

Association between pan-immune-inflammation value and dyslipidemia in the United States population DOI Creative Commons
Yu Yan, Shanshan Jia,

Xingwei Huo

et al.

Frontiers in Endocrinology, Journal Year: 2025, Volume and Issue: 16

Published: March 17, 2025

To investigate the possible association between pan-immune-inflammation value (PIV) and dyslipidemia. This cross-sectional study used data obtained from National Health Nutrition Examination Survey (NHANES). The independent variable logarithmic form of PIV-log2 (PIV). definition dyslipidemia was based on Cholesterol Education Program standards. Weighted multivariate logistic regression analyses, restricted cubic spline (RCS) threshold effect analysis were explore PIV Stratified analyses to identify potential associations with other covariates. receiver operating characteristic (ROC) curve constructed compared systemic immune-inflammation index (SII). 6,821 participants included, whom 47% male 77% had After adjusting for all confounders, an significantly positive (OR (95%CI): 1.13 (1.01-1.25); P = 0.03). Compared lowest quartile (Q1) PIV, highest (Q4) a higher risk 1.37 (1.05-1.80); 0.022). RCS showed inverted J-shaped relationship (P-nonlinear 0.0415, P-overall < 0.001). revealed that inflection point 9.192. age BMI modified PIV-dyslipidemia (P interaction 0.05). ROC found SII, similar predictive (area under (AUC): 0.566 vs 0.558; 0.073). discovered dyslipidemia, especially in young overweight individuals.

Language: Английский

Citations

0

Evolving role of double and triple therapy with GLP-1 receptor agonists in obesity and cardiovascular disease DOI
Phelopater Sedrak, Raj Verma,

Meena Verma

et al.

Canadian Journal of Cardiology, Journal Year: 2025, Volume and Issue: unknown

Published: April 1, 2025

Language: Английский

Citations

0

Systemic Inflammation Mediates the Association Between Blood Trihalomethane Concentrations and Cardiovascular Disease in U.S. Individuals Over 45: Insights from NHANES 2005–2012 DOI
Songfeng Zhao, Hongyi Liu, Hailong Zhong

et al.

Cardiovascular Toxicology, Journal Year: 2025, Volume and Issue: unknown

Published: May 14, 2025

Language: Английский

Citations

0

Breaking Boundaries: Chronic Diseases and the Frontiers of Immune Microenvironments DOI Creative Commons
Guoqing Li,

Yajuan Wan,

Alan Jiao

et al.

Published: May 22, 2025

ABSTRACT The immune microenvironment includes cells, cytokines, extracellular matrix, vesicles, etc. interactions between these components form a unique local microecology. Although immunity serves as the defense against external pathogens, aberrant activation often contributes to disease development. Chronic diseases, broad category of noncommunicable conditions characterized by long latency and prolonged course, are increasingly recognized for their intricate relationship with microenvironment. Herein, we comprehensively summarize how microenvironment, through its complex regulatory network, influences progression manifestation chronic diseases. We further explore potential targeting therapeutic strategy, aiming provide new insights directions prevention, diagnosis, treatment

Language: Английский

Citations

0

Pharmacokinetic Study of Eight Bioactive Components of Buyang Huanwu Decoction in LPS Induced Chronic Inflammatory and Control Rats Using UPLC‐MS/MS DOI
Li Jiang, Yanling Xiong, Weiwei Wang

et al.

Biomedical Chromatography, Journal Year: 2025, Volume and Issue: 39(7)

Published: May 21, 2025

ABSTRACT Inflammation plays a pivotal role in the pathogenesis of numerous chronic inflammatory diseases, including cardiovascular diseases. Buyang Huanwu decoction (BYHWD) is widely employed to treat inflammation and related disorders. However, pharmacokinetics BYHWD's active compounds under conditions remain unclear. This study aims investigate comparative eight bioactive components control LPS‐induced rats following oral administration BYHWD. A rat model was established by administering low‐dose lipopolysaccharide (LPS, 200 μg / kg) via tail vein injection. An ultra‐performance liquid chromatography–tandem mass spectrometry (UPLC‐MS/MS) method developed for simultaneous quantification major BYHWD plasma. Subsequently, pharmacokinetic profiles these analytes were characterized both rats. Excellent linearity ( R 2 > 0.9958) observed all plasma samples. Absolute recoveries ranged from 50.84% 111.86%, matrix effects varied between 85.04% 110.14%. The met criteria intra‐ inter‐day precision, accuracy, stability. In conclusion, UPLC‐MS/MS reliably investigated characteristics indicate that may reduce absorption compounds, providing valuable insights into clinical applications.

Language: Английский

Citations

0

Recent research advances in metabolism, clinical and experimental DOI
Chrysoula Boutari, Michail Kokkorakis, Konstantinos Stefanakis

et al.

Metabolism, Journal Year: 2023, Volume and Issue: 149, P. 155722 - 155722

Published: Nov. 4, 2023

Language: Английский

Citations

7